This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tang, S.
Right arrow Articles by Levin, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tang, S.
Right arrow Articles by Levin, J. G.

 Previous Article  |  Next Article 

Journal of Virology, December 2003, p. 12592-12602, Vol. 77, No. 23
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.23.12592-12602.2003

Human Immunodeficiency Virus Type 1 N-Terminal Capsid Mutants Containing Cores with Abnormally High Levels of Capsid Protein and Virtually No Reverse Transcriptase

Shixing Tang,1 Tsutomu Murakami,2,{dagger} Naiqian Cheng,3 Alasdair C. Steven,3 Eric O. Freed ,2,{ddagger} and Judith G. Levin1*

Laboratory of Molecular Genetics, National Institute of Child Health and Human Development,1 Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases,2 Laboratory of Structural Biology Research, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland 208923

Received 3 July 2003/ Accepted 27 August 2003

We previously described the phenotype associated with three alanine substitution mutations in conserved residues (Trp23, Phe40, and Asp51) in the N-terminal domain of human immunodeficiency virus type 1 capsid protein (CA). All of the mutants produce noninfectious virions that lack conical cores and, despite having a functional reverse transcriptase (RT), are unable to initiate reverse transcription in vivo. Here, we have focused on elucidating the mechanism by which these CA mutations disrupt virus infectivity. We also report that cyclophilin A packaging is severely reduced in W23A and F40A virions, even though these residues are distant from the cyclophilin A binding loop. To correlate loss of infectivity with a possible defect in an early event preceding reverse transcription, we modeled disassembly by generating viral cores from particles treated with mild nonionic detergent; cores were isolated by sedimentation in sucrose density gradients. In general, fractions containing mutant cores exhibited a normal protein profile. However, there were two striking differences from the wild-type pattern: mutant core fractions displayed a marked deficiency in RT protein and enzymatic activity (<5% of total RT in gradient fractions) and a substantial increase in the retention of CA. The high level of core-associated CA suggests that mutant cores may be unable to undergo proper disassembly. Thus, taken together with the almost complete absence of RT in mutant cores, these findings can account for the failure of the three CA mutants to synthesize viral DNA following virus entry into cells.

* Corresponding author. Mailing address: Laboratory of Molecular Genetics, NICHD, Building 6B, Room 216, NIH, Bethesda, MD 20892-2780. Phone: (301) 496-1970. Fax: (301) 496-0243. E-mail: levinju{at}mail.nih.gov.

{dagger} Present address: Department of Immunology, Graduate School and Faculty of Medicine, University of the Ryukyus, Uehara 207, Nishihara, Okinawa 903-0215, Japan.

{ddagger} Present address: HIV Drug Resistance Program, NCI-Frederick, Frederick, MD 21702-1201.

Journal of Virology, December 2003, p. 12592-12602, Vol. 77, No. 23
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.23.12592-12602.2003




This article has been cited by other articles:

  • Muller, B., Anders, M., Akiyama, H., Welsch, S., Glass, B., Nikovics, K., Clavel, F., Tervo, H.-M., Keppler, O. T., Krausslich, H.-G. (2009). HIV-1 Gag Processing Intermediates Trans-dominantly Interfere with HIV-1 Infectivity. J. Biol. Chem. 284: 29692-29703 [Abstract] [Full Text]  
  • Lee, S.-K., Harris, J., Swanstrom, R. (2009). A Strongly Transdominant Mutation in the Human Immunodeficiency Virus Type 1 gag Gene Defines an Achilles Heel in the Virus Life Cycle. J. Virol. 83: 8536-8543 [Abstract] [Full Text]  
  • Chen, J., Pathak, V. K., Peng, W., Hu, W.-S. (2008). Capsid Proteins from Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus SIVmac Can Coassemble into Mature Cores of Infectious Viruses. J. Virol. 82: 8253-8261 [Abstract] [Full Text]  
  • Warrilow, D., Meredith, L., Davis, A., Burrell, C., Li, P., Harrich, D. (2008). Cell Factors Stimulate Human Immunodeficiency Virus Type 1 Reverse Transcription In Vitro. J. Virol. 82: 1425-1437 [Abstract] [Full Text]  
  • Tian, C., Wang, T., Zhang, W., Yu, X.-F. (2007). Virion packaging determinants and reverse transcription of SRP RNA in HIV-1 particles. Nucleic Acids Res 35: 7288-7302 [Abstract] [Full Text]  
  • Auerbach, M. R., Brown, K. R., Singh, I. R. (2007). Mutational Analysis of the N-Terminal Domain of Moloney Murine Leukemia Virus Capsid Protein. J. Virol. 81: 12337-12347 [Abstract] [Full Text]  
  • Yang, R., Aiken, C. (2007). A Mutation in Alpha Helix 3 of CA Renders Human Immunodeficiency Virus Type 1 Cyclosporin A Resistant and Dependent: Rescue by a Second-Site Substitution in a Distal Region of CA. J. Virol. 81: 3749-3756 [Abstract] [Full Text]  
  • Spidel, J. L., Wilson, C. B., Craven, R. C., Wills, J. W. (2007). Genetic Studies of the {beta}-Hairpin Loop of Rous Sarcoma Virus Capsid Protein. J. Virol. 81: 1288-1296 [Abstract] [Full Text]  
  • Leschonsky, B., Ludwig, C., Bieler, K., Wagner, R. (2007). Capsid stability and replication of human immunodeficiency virus type 1 are influenced critically by charge and size of Gag residue 183. J. Gen. Virol. 88: 207-216 [Abstract] [Full Text]  
  • Auerbach, M. R., Brown, K. R., Kaplan, A., de Las Nueces, D., Singh, I. R. (2006). A Small Loop in the Capsid Protein of Moloney Murine Leukemia Virus Controls Assembly of Spherical Cores. J. Virol. 80: 2884-2893 [Abstract] [Full Text]  
  • Gurer, C., Hoglund, A., Hoglund, S., Luban, J. (2005). ATP{gamma}S Disrupts Human Immunodeficiency Virus Type 1 Virion Core Integrity. J. Virol. 79: 5557-5567 [Abstract] [Full Text]  
  • Scholz, I., Arvidson, B., Huseby, D., Barklis, E. (2005). Virus Particle Core Defects Caused by Mutations in the Human Immunodeficiency Virus Capsid N-Terminal Domain. J. Virol. 79: 1470-1479 [Abstract] [Full Text]  
  • Melamed, D., Mark-Danieli, M., Kenan-Eichler, M., Kraus, O., Castiel, A., Laham, N., Pupko, T., Glaser, F., Ben-Tal, N., Bacharach, E. (2004). The Conserved Carboxy Terminus of the Capsid Domain of Human Immunodeficiency Virus Type 1 Gag Protein Is Important for Virion Assembly and Release. J. Virol. 78: 9675-9688 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»